Latest News

New research has suggested that rejuvenating an older person’s blood stem cells may now be within reach.

Researchers have used machine learning to identify genes related to smoking behaviors and find existing medications that may be able to be repurposed to help people quit smoking.

Scientists at University of California San Diego School of Medicine have developed an artificial intelligence (AI)-based strategy for discovering high-affinity antibody drugs.

A new molecule could offer non-hormonal contraceptive options for people who produce sperm, according to new research published in The American Chemical Society (ACS)’s Journal of Medicinal Chemistry.

Findings from a new study emphasize the benefits of combinations of antibodies over monotherapy approaches for targeting the Ebola virus.

A preclinical study from Scripps Research has shown that an experimental antidepressant also shows promise as a treatment for alcohol use disorder.

New Cornell research is providing a fresh view into the ways a common chemotherapy agent, etoposide, stalls and poisons the essential enzymes that allow cancer cells to flourish.

A newly published paper shows that an experimental vaccine against Marburg virus (MARV) was safe and induced an immune response in a small, first-in-human clinical trial.

Researchers at MIT, Nanyang Technological University in Singapore, the Pasteur Institute in Paris, and other institutions have now designed a microfluidic device, or “spleen-on-a-chip,” that can model how acute splenic sequestration arises.

The world’s first international clinical guidelines to help prevent and treat heart complications in children undergoing cancer treatment have been created.